Wangrui Liu

8PUBLICATIONS
14CO-AUTHORS
Liquid biopsiesSolid tumoursMolecular targetsCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 21, 2026
Iatrogenic Aerogenous Tumor Spread after CT-guided Lung Biopsy.

|Jan 15, 2024
Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma.

Wenhao Xu, Jiahe Lu, Xi Tian

|Jul 18, 2023
Targeting RAS guanyl releasing protein 1 promotes T lymphocytes infiltrations and improves anti-programmed death receptor ligand 1 therapy response of triple-negative breast cancer.

Xi Chen, Yuanliang Yan, Wangrui Liu

|May 17, 2022
Special issue "The advance of solid tumor research in China": Multi-omics analysis based on 1311 clear cell renal cell carcinoma samples identifies a glycolysis signature associated with prognosis and treatment response.

Xi Tian, Yue Wang, Wenhao Xu

|Oct 28, 2021
Adenylate cyclase-activating polypeptide 1 gene methylation predicts prognosis and the immune microenvironment of bladder cancer.

Wenhao Xu, Aihetaimujiang Anwaier, Wangrui Liu

|May 18, 2021
Traditional Chinese medicine Bu-Shen-Jian-Pi-Fang attenuates glycolysis and immune escape in clear cell renal cell carcinoma: results based on network pharmacology.

Jinzhou Zheng, Wenhao Xu, Wangrui Liu

Pageof 2

Frequent Collaborators

4 joint publications

Wenhao Xu

2 joint publications

Xi Tian

1 joint publications

Manhui Zhu

1 joint publications

Jianfeng Yang